SCHEMBL4138697

SCHEMBL4138697

N#Cc1c(Cl)cccc1SSc1cccc(Cl)c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PSMB8 P28062 4/20 0.38
PSMB5 P28074 1/20 0.38
DYRK1A Q13627 2/20 0.38
HSD11B1 P28845 1/20 0.37
GAA P10253 2/20 0.36
MPO P05164 1/20 0.36
NOTUM Q6P988 1/20 0.35
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8494974 0.83 KDM4E (0.43) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
Dichlobenil SCHEMBL55606 0.81 ALDH1A1 (0.55) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
Dichlobenil SCHEMBL1701380 0.81 ALDH1A1 (0.55) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
SCHEMBL8779801 0.80 KDM4E (0.41) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
SCHEMBL11326735 0.79 MAOA (0.44) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
Dichlobenil SCHEMBL10737856 0.79 ALDH1A1 (0.53) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
Dichlobenil SCHEMBL28232070 0.79 ALDH1A1 (0.53) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
Dichlobenil SCHEMBL10741379 0.77 ALDH1A1 (0.52) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
SCHEMBL9129444 0.76 CYP1A2 (0.57) KDM4EALDH1A1L3MBTL1CYP1A2CYP3A4
SCHEMBL3458187 0.76 CYP1A2 (0.42) KDM4EALDH1A1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069317-A1 Insecticidal Methods Using 3-Amino-1,2-Benzisothiazole Derivatives BASF SE (DE) 2009-03-12 US disclosed
EP-1954138-A2 INSECTICIDAL METHODS USING 3-AMINO-1,2-BENZISOTHIAZOLE DERIVATIVES BASF SE (DE) 2008-08-13 EP disclosed
WO-2007057407-A2 INSECTICIDAL METHODS USING 3-AMINO-1,2-BENZISOTHIAZOLE DERIVATIVES BASF SE (DE) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069317-A1 Insecticidal Methods Using 3-Amino-1,2-Benzisothiazole Derivatives AAAS, API5, ATL3 KDM4E 1247/4885ALDH1A1 731/4885L3MBTL1 146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.